Factory Supply Medical Neolistat Powder Cetilistat CAS 282526-98-1 Atl-962

• Powder: Yes
• Customized: Customized
• Certification: ISO 9001
• Suitable for: Elderly, Adult
• Purity: >99%
• Product Name: Cetilistat
• Model NO.: YT0432
• Appearance: White Powder
• MOQ: 10gram
• Shelf Life: 2 Years
• Test Method: HPLC
• Sample: Availiable
• Packing: Vacuum Packed, Drum
• Storage: Sealed in Dry, 2-8°c
• Molecular Formula: C25h39no3
• Molecular Weight: 401.58
• Einecs: 1308068-626-2
• Melting Point: 72.0 to 76.0 °c
• Boiling Point: 509.7±43.0 °c(Predicted)
• Transport Package: Packing 1kg/Bag or 25kg/Drum
• Specification: 99%
• Trademark: YTBIO
• Origin: Shaanxi, China

Product Description

Cetilistat (atl-962), also known as cetilistat, is a new gastrointestinal lipase inhibitor developed by alizyme
company in the UK. Later, "norgina bv" company obtained the global agency right of "cetilistat chemicalbook".
Cetiriestat is in phase 3 clinical trial in the United States. In Japan, due to cooperation with Takeda pharmaceutical,
xinlistat was approved as a drug for the treatment of obesity in September 2013. The trade name is "oblean".

Product Name	Cetilistat
CAS No.	282526-98-1
M.F.	C25H39NO3
M.W.	401.58
EINECS No	1308068-626-2
Appearance	White powder
Purity	99%
Package	Bag/drum/OEM

Neolistat is a long-acting and powerful specific gastrointestinal lipase inhibitor. It plays a therapeutic role by
forming covalent bonds with the active serine sites of gastric lipase and pancreatic lipase in the stomach and
small intestine. The inactivated enzyme cannot hydrolyze the fat in food, mainly triglycerides, into absorbable
free fatty acids and monoacylglycerides, Undigested triglycerides cannot be absorbed by the body, so as to
reduce calorie intake and control weight.

New lestar is a new type of pancreatic lipase inhibitor used to treat obesity in diabetic and non-diabetic patients.
Main purpose:
1. New weight loss drugs
2. It can be used to quit smoking